# TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

> **NCT00107887** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 17415 (actual)

## Conditions studied

- Tuberculosis
- HIV Infections

## Interventions

- **DRUG:** INH preventive therapy
- **DRUG:** TST (tuberculin skin test)

## Key facts

- **NCT ID:** NCT00107887
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 17415 (ACTUAL)
- **Last updated:** 2011-06-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00107887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00107887, "TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00107887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*